Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.5 USD | +9.01% | -2.34% | -20.63% |
Jan. 31 | Transcript : Regis Corporation, Q2 2024 Earnings Call, Jan 31, 2024 | |
Jan. 31 | Regis Corporation Provides Strategic Review Update | CI |
Financials (USD)
Sales 2022 | 276M | Sales 2023 | 233M | Capitalization | 50.58M |
---|---|---|---|---|---|
Net income 2022 | -85M | Net income 2023 | -7M | EV / Sales 2022 | 2.62 x |
Net Debt 2022 | 675M | Net Debt 2023 | 541M | EV / Sales 2023 | 2.54 x |
P/E ratio 2022 |
-0.38
x | P/E ratio 2023 |
-6.95
x | Employees | 397 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.58% |
Latest transcript on Regis Corporation
1 day | +9.01% | ||
1 week | -2.34% | ||
Current month | -10.61% | ||
1 month | -10.18% | ||
3 months | -28.16% | ||
6 months | -46.34% | ||
Current year | -20.63% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Doctor
CEO | Chief Executive Officer | 37 | 21-01-31 |
Kersten Zupfer
DFI | Director of Finance/CFO | 49 | 06-12-31 |
Jim Lain
COO | Chief Operating Officer | 60 | 13-11-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Mansbach
BRD | Director/Board Member | 56 | 21-06-13 |
Margaret Rhoades
BRD | Director/Board Member | 79 | 15-10-19 |
Michael Merriman
BRD | Director/Board Member | 67 | 11-10-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 7.5 | +9.01% | 5,404 |
24-03-27 | 6.88 | -3.10% | 5,741 |
24-03-26 | 7.1 | -3.53% | 4,574 |
24-03-25 | 7.36 | -5.64% | 12,573 |
24-03-22 | 7.8 | +1.56% | 3,977 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-20.63% | 15.68M | |
-4.49% | 618M | |
-3.03% | 501M | |
+39.53% | 465M | |
+11.21% | 301M | |
-24.71% | 198M | |
-18.07% | 106M | |
+2.15% | 89.66M | |
-16.39% | 74.78M | |
-5.52% | 70.04M |